[1]World Health Organization. Naming the coronavirus disease (COVID-19) and the virus that causes it [EB/OL].
[2020-02-11].
[2]Chan KW, Wong VT, Tang SCW.COVID-19: An Update on the Epidemiological, Clinical, Preventive and Therapeutic Evidence and Guidelines of Integrative Chinese-Western Medicine for the Management of 2019 Novel Coronavirus Disease[J]. Am J Chin Med, 2020,48(3):737-762.
[3]Wu Z, McGoogan JM. Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72314 Cases From the Chinese Center for Disease Control andPrevention[J]. JAMA, 2020,323(13):1239-1242.
[4]谭晓契,钱治军,张宏伟.全国新型冠状病毒肺炎疫情初期治愈和死亡情况初步分析[J/OL] .上海预防医学,2020,32 (2020-03-24).
[5]Zhou F, Yu T, Du R, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study[J]. Lancet, 2020. Published online March 9, 2020.
[6]Mo P, Xing Y, Xiao Y, et al. Clinical characteristics of refractory COVID-19 pneumonia in Wuhan, China[J].Clin Infect Dis, 2020. doi: 10.1093/cid/ciaa270.
[7]Chen N, Zhou M, Dong X, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study[J]. Lancet, 2020,395(10223): 507-513.
[8]Guan WJ, Ni ZY, Hu Y, et al. Clinical characteristics of coronavirus disease 2019 in China[J/OL].N Engl J Med, 2020[published online ahead of print, 2020 Feb 28].
[9]Wang Z, Yang B, Li Q, et al. Clinical Features of 69 Cases with Coronavirus Disease 2019 in Wuhan, China[J]. Clin Infect Dis,2020[published online ahead of print, 2020 Mar 17].
[10]Wang D, Hu B, Hu C, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China[J]. JAMA, 2020(published online ahead of print, 2020 Feb )
[2020-02-11].
[11]Zheng HY, Zhang M, Yang CX, et al. Elevated exhaustion levels and reduced functional diversity of T cells in peripheral blood may predict severe progression in COVID-19 patients[J]. Cell Mol Immunol, 2020,17(5):541-543.
[1]阳文新,何咸兵,王跃华,等.肝移植术后弥漫性脑病的特点及危险因素分析[J].医学研究与战创伤救治(原医学研究生学报),2012,14(05):396.
YANG Wen-xin,HE Xian-bing,WANG Yue-hua,et al.Features of diffuse encephalopathy after liver transplantation and its risk factors[J].JOURNAL OF MEDICALRESEARCH —COMBAT TRAUMA CARE,2012,14(04):396.
[2]曾素琴,陈小芳,吴金飞,等.出血性脑梗死相关危险因素及预后分析[J].医学研究与战创伤救治(原医学研究生学报),2012,14(05):422.
ZENG Su-qin,CHEN Xiao-fang,WU Jin-fei,et al.Analysis of related risk factors and prognosis to cerebral hemorrhagic infarction[J].JOURNAL OF MEDICALRESEARCH —COMBAT TRAUMA CARE,2012,14(04):422.
[3]徐桂芳,张建东,赵海滨,等.E-钙粘蛋白和MMP-9在胃癌组织中的表达及其临床意义[J].医学研究与战创伤救治(原医学研究生学报),2010,12(04):308.
XU Gui-fang,ZHANG Jian-dong,ZHAO Hai-bin,et al.Expression and significance of E-Cadherin and matrix metalloproteinase-9 in gastric carcinoma[J].JOURNAL OF MEDICALRESEARCH —COMBAT TRAUMA CARE,2010,12(04):308.
[4]王良馥,陈自力,熊建生,等.急性创伤性血胸凝血功能异常的临床研究[J].医学研究与战创伤救治(原医学研究生学报),2009,11(02):100.
WANG Liang-fu,CHEN Zi-li,XIONG Jian-sheng,et al.Clinical study of blood coagulation and fibrinolysin in acute traumatic hemothorax[J].JOURNAL OF MEDICALRESEARCH —COMBAT TRAUMA CARE,2009,11(04):100.
[5]夏向南,缪海雄,陈 华.脑利钠肽对老年心力衰竭预后的
初步评估[J].医学研究与战创伤救治(原医学研究生学报),2008,10(05):326.
XIA Xiang-nan,MIAO Hai-xiong,CHEN Hua.The initial evaluation of BNP to the prognosis of heart failure in elderly patients[J].JOURNAL OF MEDICALRESEARCH —COMBAT TRAUMA CARE,2008,10(04):326.
[6]黄凤楼,刁孟元,钱海飞,等.降钙素原及内毒素对腹腔感染脓毒症患者预后的评估[J].医学研究与战创伤救治(原医学研究生学报),2014,16(02):147.[doi:10.3969/j.issn.1672-271X.2014.02.011]
HUANG Feng-lou,DIAO Meng-yuan,QIAN Hai-fei,et al.Prognostic value of procalcitonin and endotoxin concentrations for intra-abdominal sepsis[J].JOURNAL OF MEDICALRESEARCH —COMBAT TRAUMA CARE,2014,16(04):147.[doi:10.3969/j.issn.1672-271X.2014.02.011]
[7]谷 欣,桑云华,龙宏杰.腹内压变化率对评估腹腔内高压症患者病情及预后的价值[J].医学研究与战创伤救治(原医学研究生学报),2014,16(03):246.[doi:10.3969/j.issn.1672-271X.2014.03.007]
GU Xin,SANG Yun-hua,LONG Hong-jie..The value of the rate of intra-abdominal pressure in evaluating for the condition and prognosis of IAH patients[J].JOURNAL OF MEDICALRESEARCH —COMBAT TRAUMA CARE,2014,16(04):246.[doi:10.3969/j.issn.1672-271X.2014.03.007]
[8]崔广清,冒秀宏,孙卫和,等.PiCCO指导重症患者液体管理及临床预后的评价[J].医学研究与战创伤救治(原医学研究生学报),2015,17(02):122.[doi:10.3969/j.issn.1672-271X.2015.02.004]
CUI Guang-qing,MAO Xiu-hong,SUN Wei-he,et al.Study of the fluid responsiveness and outcomes of patients who receive PiCCO[J].JOURNAL OF MEDICALRESEARCH —COMBAT TRAUMA CARE,2015,17(04):122.[doi:10.3969/j.issn.1672-271X.2015.02.004]
[9]蒋娅综述,李波审校.急性肺栓塞合并右心功能不全的诊断及预后评估[J].医学研究与战创伤救治(原医学研究生学报),2015,17(05):520.[doi:10.3969/j.issn.1672-271X.2015.05.023]
[10]李亮,曹昌魁,聂时南.小剂量氢化可的松治疗严重脓毒症患者的疗效观察[J].医学研究与战创伤救治(原医学研究生学报),2016,18(05):455.[doi:10.3969/j.issn.1672-271X.2016.05.002]
LI Liang,CAO Chang-kui,NIE Shi-nan..A clinical research of low-dose hydrocortisone treatment in severe sepsis[J].JOURNAL OF MEDICALRESEARCH —COMBAT TRAUMA CARE,2016,18(04):455.[doi:10.3969/j.issn.1672-271X.2016.05.002]
[11]蔡玉龙,刘炯,夏国际,等.托珠单抗治疗高龄新型冠状病毒肺炎患者的临床疗效[J].医学研究与战创伤救治(原医学研究生学报),2021,23(01):75.[doi:10.3969/j.issn.1672-271X.2021.01.001]